2018
DOI: 10.1016/j.devcel.2018.05.033
|View full text |Cite
|
Sign up to set email alerts
|

EMT in Metastasis: Finding the Right Balance

Abstract: The epithelial-to-mesenchymal transition (EMT) is a key driver of cancer metastasis. In this issue of Developmental Cell, Aiello et al. (2018) demonstrate that an EMT mechanism involving protein internalization impacts cell migration, while Reichert et al. (2018) identify epithelial plasticity as a determinant of metastatic organotropism in pancreatic cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
34
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(35 citation statements)
references
References 10 publications
(11 reference statements)
1
34
0
Order By: Relevance
“…Transitions between epithelial and mesenchymal phenotypes (the epithelial to mesenchymal transition [EMT] and its reverse, the mesenchymal to epithelial transition [MET]), are hallmarks of cancer metastasis . The connection among EMT, MET and stemness indicates that CSC come in two distinct states: “epithelial‐like” and “mesenchymal‐like.” Recent studies have attempted to resolve this contradiction by suggesting that instead of the cells in pure epithelial (E) or pure mesenchymal (M) states, cells in hybrid E/M or partial EMT state (which express epithelial and mesenchymal markers concurrently) are most likely to gain stemness . In fact, many CTC that survive in blood exhibit hybrid E/M phenotypes, become resistant to drugs and exit the bloodstream more efficiently .…”
Section: Introductionmentioning
confidence: 99%
“…Transitions between epithelial and mesenchymal phenotypes (the epithelial to mesenchymal transition [EMT] and its reverse, the mesenchymal to epithelial transition [MET]), are hallmarks of cancer metastasis . The connection among EMT, MET and stemness indicates that CSC come in two distinct states: “epithelial‐like” and “mesenchymal‐like.” Recent studies have attempted to resolve this contradiction by suggesting that instead of the cells in pure epithelial (E) or pure mesenchymal (M) states, cells in hybrid E/M or partial EMT state (which express epithelial and mesenchymal markers concurrently) are most likely to gain stemness . In fact, many CTC that survive in blood exhibit hybrid E/M phenotypes, become resistant to drugs and exit the bloodstream more efficiently .…”
Section: Introductionmentioning
confidence: 99%
“…Depending on the characteristics of the primary tumor, the stroma, and the intrinsic ability of metastatic tumor cells to adapt to a new location, malignant cells use distinct mechanisms for proliferation, survival, and dissemination. These cells often reactivate the expression of genes employed during embryogenesis [17,18]. In order to leave the primary tumor and disseminate to distant organs, metastatic cells lose the ability to adhere to adjacent cells, enhancing their migratory and invasive capacity.…”
Section: Discussionmentioning
confidence: 99%
“…In order to leave the primary tumor and disseminate to distant organs, metastatic cells lose the ability to adhere to adjacent cells, enhancing their migratory and invasive capacity. This mechanism is accompanied by several modifications in the expression of genes, such as loss of epithelial receptor expression and increased expression of mesenchymal markers, a phenomenon also known as epithelial-mesenchymal transition [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…Focusing on the diverse regulated molecules, multiple drugs have shown their potential as EMT inhibitors by targeting the tumor microenvironment, corresponding extracellular receptors, intracellular kinases and EMT inducing transcription factors [15]. As its well-described clinical signature of EMT in cancer development, therapeutic strategies and targeted drugs towards EMT have been involved in cancer treatment [16][17][18].NF-κB is an important transcription factor involved in multiple biologic processes as immune response, stress response, apoptosis, cell proliferation and cell metastasis [18]. The abnormal activation of NF-κB has been regarded as a hallmark of cancer, which promotes both tumorigenesis and tumor development [19][20][21].…”
mentioning
confidence: 99%
“…Focusing on the diverse regulated molecules, multiple drugs have shown their potential as EMT inhibitors by targeting the tumor microenvironment, corresponding extracellular receptors, intracellular kinases and EMT inducing transcription factors [15]. As its well-described clinical signature of EMT in cancer development, therapeutic strategies and targeted drugs towards EMT have been involved in cancer treatment [16][17][18].…”
mentioning
confidence: 99%